Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults

por Faison, Shamia L., Fry, Nicholas, Adewole, Toyin, Odebo, Oyinkansola, Wang, Zhao, Maletic, Vladimir, Nasser, Azmi
Publicado 2021

Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (Qelbree(TM)) in Healthy Adult Subjects

por Wang, Zhao, Kosheleff, Alisa R, Adeojo, Lilian W, Odebo, Oyinkansola, Liranso, Tesfaye, Schwabe, Stefan, Nasser, Azmi
Publicado 2021

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults

por Faison, Shamia L., Fry, Nicholas, Adewole, Toyin, Odebo, Oyinkansola, Schwabe, Stefan, Wang, Zhao, Maletic, Vladimir, Nasser, Azmi
Publicado 2020

Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN‐812 (Viloxazine Extended‐Release) Pharmacokinetics in Healthy Adults

por Wang, Zhao, Kosheleff, Alisa R., Adeojo, Lilian W., Odebo, Oyinkansola, Adewole, Toyin, Qin, Peibing, Maletic, Vladimir, Schwabe, Stefan, Nasser, Azmi
Publicado 2021

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperacti...

por Nasser, Azmi, Hull, Joseph T., Chaturvedi, Soumya A., Liranso, Tesfaye, Odebo, Oyinkansola, Kosheleff, Alisa R., Fry, Nicholas, Cutler, Andrew J., Rubin, Jonathan, Schwabe, Stefan, Childress, Ann
Publicado 2022